Kerecis SecureMesh
Mesh, Surgical, Collagen, Staple Line Reinforcement. 510(k) K153364, from Kerecis Limited (Isafjordur, IS). Product code OXE, class 2.
As of Nov 19, 2026, K153364 is an FDA 510(k) held by Kerecis Limited, substantially equivalent on Aug 19, 2016 after 273 days, with no recalls tied to it in FDA's recall database.
- Review time: 273 days
- Recalls: 0
- Cited as a predicate by: 3 devices
Kerecis SecureMesh is intended for use as a prosthesis when staple line reinforcement is needed in surgical repair of soft tissue deficiencies using surgical staplers. Kerecis SecureMesh can be used for reinforcement of staple lines during: - Bariatric surgical procedures - Colorectal and Colon surgical procedures - Gastric, small bowels and mesentery procedures - Lung and bronchus resections
- Veritas Dry Collagen Matrix, Veritas Dry Or Veritas PsdK041669 · Synovis Surgical Innovations · Oct 27, 2004
- Marigen Wound DressingK132343 · Kerecis Limited · Oct 23, 2013
- Peri-Strips Staple Line Reinforcement - Sleeve and Strip Configurations - and Peri-Strips Dry Staple Line ReinforcementK040415 · Synovis Surgical Innovations · Apr 14, 2004
- Kerecis OralK213904 · Kerecis · Sep 30, 2022
- Kerecis Gingiva GraftK192612 · Kerecis Limited · Nov 13, 2020
- MariGen Wound ExtraK190528 · Kerecis Limited · Jul 10, 2019
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 20, 2015
- Review panel
- General, Plastic Surgery
- Regulation
- 21 CFR 878.3300
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files